nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—CYP3A4—urine—polycystic ovary syndrome	0.0354	0.0676	CbGeAlD
Zaleplon—TSPO—embryo—polycystic ovary syndrome	0.0246	0.047	CbGeAlD
Zaleplon—AOX1—adrenal cortex—polycystic ovary syndrome	0.0236	0.0451	CbGeAlD
Zaleplon—CYP3A7—endocrine gland—polycystic ovary syndrome	0.0222	0.0424	CbGeAlD
Zaleplon—AOX1—endometrium—polycystic ovary syndrome	0.0211	0.0403	CbGeAlD
Zaleplon—TSPO—adrenal cortex—polycystic ovary syndrome	0.0202	0.0385	CbGeAlD
Zaleplon—AOX1—uterus—polycystic ovary syndrome	0.0194	0.0371	CbGeAlD
Zaleplon—GABRG2—pituitary gland—polycystic ovary syndrome	0.0193	0.0368	CbGeAlD
Zaleplon—AOX1—pituitary gland—polycystic ovary syndrome	0.0191	0.0365	CbGeAlD
Zaleplon—AOX1—adipose tissue—polycystic ovary syndrome	0.019	0.0363	CbGeAlD
Zaleplon—TSPO—endometrium—polycystic ovary syndrome	0.018	0.0344	CbGeAlD
Zaleplon—GABRA2—adipose tissue—polycystic ovary syndrome	0.0175	0.0335	CbGeAlD
Zaleplon—AOX1—adrenal gland—polycystic ovary syndrome	0.017	0.0326	CbGeAlD
Zaleplon—TSPO—uterus—polycystic ovary syndrome	0.0166	0.0317	CbGeAlD
Zaleplon—TSPO—pituitary gland—polycystic ovary syndrome	0.0163	0.0311	CbGeAlD
Zaleplon—TSPO—adipose tissue—polycystic ovary syndrome	0.0162	0.031	CbGeAlD
Zaleplon—AOX1—female gonad—polycystic ovary syndrome	0.0159	0.0304	CbGeAlD
Zaleplon—AOX1—vagina—polycystic ovary syndrome	0.0158	0.0302	CbGeAlD
Zaleplon—GABRA2—adrenal gland—polycystic ovary syndrome	0.0157	0.03	CbGeAlD
Zaleplon—GABRB3—pituitary gland—polycystic ovary syndrome	0.0148	0.0283	CbGeAlD
Zaleplon—AOX1—endocrine gland—polycystic ovary syndrome	0.0148	0.0282	CbGeAlD
Zaleplon—GABRA2—vagina—polycystic ovary syndrome	0.0146	0.0278	CbGeAlD
Zaleplon—TSPO—adrenal gland—polycystic ovary syndrome	0.0146	0.0278	CbGeAlD
Zaleplon—TSPO—female gonad—polycystic ovary syndrome	0.0136	0.0259	CbGeAlD
Zaleplon—TSPO—vagina—polycystic ovary syndrome	0.0135	0.0258	CbGeAlD
Zaleplon—TSPO—endocrine gland—polycystic ovary syndrome	0.0126	0.0241	CbGeAlD
Zaleplon—GABRB3—endocrine gland—polycystic ovary syndrome	0.0115	0.0219	CbGeAlD
Zaleplon—CYP3A5—adipose tissue—polycystic ovary syndrome	0.0101	0.0192	CbGeAlD
Zaleplon—CYP3A5—female gonad—polycystic ovary syndrome	0.00841	0.0161	CbGeAlD
Zaleplon—CYP3A5—vagina—polycystic ovary syndrome	0.00836	0.016	CbGeAlD
Zaleplon—Neuropathy—Metformin—polycystic ovary syndrome	0.00818	0.0429	CcSEcCtD
Zaleplon—CYP3A5—endocrine gland—polycystic ovary syndrome	0.00782	0.0149	CbGeAlD
Zaleplon—Ear pain—Metformin—polycystic ovary syndrome	0.00742	0.0389	CcSEcCtD
Zaleplon—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00648	0.034	CcSEcCtD
Zaleplon—Migraine—Metformin—polycystic ovary syndrome	0.00623	0.0327	CcSEcCtD
Zaleplon—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00587	0.0112	CbGeAlD
Zaleplon—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00584	0.0306	CcSEcCtD
Zaleplon—Breast disorder—Metformin—polycystic ovary syndrome	0.00572	0.03	CcSEcCtD
Zaleplon—Angina pectoris—Metformin—polycystic ovary syndrome	0.00533	0.0279	CcSEcCtD
Zaleplon—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00478	0.0251	CcSEcCtD
Zaleplon—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00461	0.0242	CcSEcCtD
Zaleplon—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00435	0.0228	CcSEcCtD
Zaleplon—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00431	0.0226	CcSEcCtD
Zaleplon—Eye disorder—Metformin—polycystic ovary syndrome	0.00409	0.0215	CcSEcCtD
Zaleplon—Immune system disorder—Metformin—polycystic ovary syndrome	0.00395	0.0207	CcSEcCtD
Zaleplon—Chills—Metformin—polycystic ovary syndrome	0.00393	0.0206	CcSEcCtD
Zaleplon—Malnutrition—Metformin—polycystic ovary syndrome	0.00381	0.02	CcSEcCtD
Zaleplon—Flatulence—Metformin—polycystic ovary syndrome	0.00375	0.0197	CcSEcCtD
Zaleplon—Dysgeusia—Metformin—polycystic ovary syndrome	0.00373	0.0196	CcSEcCtD
Zaleplon—Tremor—Metformin—polycystic ovary syndrome	0.00357	0.0187	CcSEcCtD
Zaleplon—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00354	0.0185	CcSEcCtD
Zaleplon—Malaise—Metformin—polycystic ovary syndrome	0.00344	0.018	CcSEcCtD
Zaleplon—Syncope—Metformin—polycystic ovary syndrome	0.00342	0.0179	CcSEcCtD
Zaleplon—Palpitations—Metformin—polycystic ovary syndrome	0.00337	0.0177	CcSEcCtD
Zaleplon—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00335	0.0176	CcSEcCtD
Zaleplon—Hypertension—Metformin—polycystic ovary syndrome	0.00329	0.0173	CcSEcCtD
Zaleplon—Chest pain—Metformin—polycystic ovary syndrome	0.00324	0.017	CcSEcCtD
Zaleplon—Myalgia—Metformin—polycystic ovary syndrome	0.00324	0.017	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00322	0.0169	CcSEcCtD
Zaleplon—Discomfort—Metformin—polycystic ovary syndrome	0.0032	0.0168	CcSEcCtD
Zaleplon—Oedema—Metformin—polycystic ovary syndrome	0.00311	0.0163	CcSEcCtD
Zaleplon—Shock—Metformin—polycystic ovary syndrome	0.00306	0.016	CcSEcCtD
Zaleplon—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00305	0.016	CcSEcCtD
Zaleplon—Skin disorder—Metformin—polycystic ovary syndrome	0.00302	0.0158	CcSEcCtD
Zaleplon—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00301	0.0158	CcSEcCtD
Zaleplon—Anorexia—Metformin—polycystic ovary syndrome	0.00296	0.0155	CcSEcCtD
Zaleplon—Hypotension—Metformin—polycystic ovary syndrome	0.00291	0.0152	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00283	0.0149	CcSEcCtD
Zaleplon—Paraesthesia—Metformin—polycystic ovary syndrome	0.00279	0.0146	CcSEcCtD
Zaleplon—Dyspnoea—Metformin—polycystic ovary syndrome	0.00277	0.0145	CcSEcCtD
Zaleplon—Somnolence—Metformin—polycystic ovary syndrome	0.00276	0.0145	CcSEcCtD
Zaleplon—Dyspepsia—Metformin—polycystic ovary syndrome	0.00274	0.0144	CcSEcCtD
Zaleplon—Decreased appetite—Metformin—polycystic ovary syndrome	0.0027	0.0142	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00268	0.0141	CcSEcCtD
Zaleplon—Constipation—Metformin—polycystic ovary syndrome	0.00266	0.0139	CcSEcCtD
Zaleplon—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00256	0.0134	CcSEcCtD
Zaleplon—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00254	0.0133	CcSEcCtD
Zaleplon—Urticaria—Metformin—polycystic ovary syndrome	0.00247	0.013	CcSEcCtD
Zaleplon—Abdominal pain—Metformin—polycystic ovary syndrome	0.00246	0.0129	CcSEcCtD
Zaleplon—Asthenia—Metformin—polycystic ovary syndrome	0.00223	0.0117	CcSEcCtD
Zaleplon—Pruritus—Metformin—polycystic ovary syndrome	0.0022	0.0115	CcSEcCtD
Zaleplon—Dizziness—Metformin—polycystic ovary syndrome	0.00206	0.0108	CcSEcCtD
Zaleplon—Rash—Metformin—polycystic ovary syndrome	0.00196	0.0103	CcSEcCtD
Zaleplon—Dermatitis—Metformin—polycystic ovary syndrome	0.00196	0.0103	CcSEcCtD
Zaleplon—Headache—Metformin—polycystic ovary syndrome	0.00195	0.0102	CcSEcCtD
Zaleplon—Nausea—Metformin—polycystic ovary syndrome	0.00185	0.00969	CcSEcCtD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.001	0.00351	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000989	0.00346	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000984	0.00344	CbGpPWpGaD
Zaleplon—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000983	0.00344	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000982	0.00344	CbGpPWpGaD
Zaleplon—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000978	0.00342	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00097	0.00339	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000969	0.00339	CbGpPWpGaD
Zaleplon—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000965	0.00338	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.000951	0.00333	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000929	0.00325	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000927	0.00324	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000921	0.00322	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000915	0.0032	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000913	0.0032	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.000904	0.00316	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.0009	0.00315	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.000894	0.00313	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00086	0.00301	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000859	0.00301	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000857	0.003	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.000826	0.00289	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—TEAD2—polycystic ovary syndrome	0.000825	0.00289	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000825	0.00289	CbGpPWpGaD
Zaleplon—CYP3A7—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000817	0.00286	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000803	0.00281	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000801	0.0028	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000798	0.00279	CbGpPWpGaD
Zaleplon—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000793	0.00277	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00079	0.00277	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00079	0.00277	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000784	0.00274	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000766	0.00268	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—DLG4—polycystic ovary syndrome	0.000758	0.00265	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000756	0.00265	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.000754	0.00264	CbGpPWpGaD
Zaleplon—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000729	0.00255	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000723	0.00253	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000718	0.00251	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000713	0.00249	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000713	0.00249	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—DLG4—polycystic ovary syndrome	0.00071	0.00249	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00071	0.00248	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—DLG4—polycystic ovary syndrome	0.000706	0.00247	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000703	0.00246	CbGpPWpGaD
Zaleplon—AOX1—Disease—RPL37A—polycystic ovary syndrome	0.000702	0.00246	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.0007	0.00245	CbGpPWpGaD
Zaleplon—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000697	0.00244	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—DLG4—polycystic ovary syndrome	0.000693	0.00242	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000691	0.00242	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.000685	0.0024	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000668	0.00234	CbGpPWpGaD
Zaleplon—AOX1—Disease—HMMR—polycystic ovary syndrome	0.000665	0.00233	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000661	0.00231	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00066	0.00231	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.000659	0.0023	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000655	0.00229	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000651	0.00228	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—STAR—polycystic ovary syndrome	0.000625	0.00219	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000621	0.00217	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—DLG4—polycystic ovary syndrome	0.000606	0.00212	CbGpPWpGaD
Zaleplon—CYP3A5—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000591	0.00207	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000582	0.00204	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000578	0.00202	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000574	0.00201	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000564	0.00197	CbGpPWpGaD
Zaleplon—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000562	0.00197	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HMMR—polycystic ovary syndrome	0.000557	0.00195	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000556	0.00195	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKR1C1—polycystic ovary syndrome	0.000548	0.00192	CbGpPWpGaD
Zaleplon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000541	0.00189	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000531	0.00186	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000522	0.00183	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000515	0.0018	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NMNAT3—polycystic ovary syndrome	0.000512	0.00179	CbGpPWpGaD
Zaleplon—AOX1—Disease—FGF18—polycystic ovary syndrome	0.000508	0.00178	CbGpPWpGaD
Zaleplon—AOX1—Disease—RBP4—polycystic ovary syndrome	0.000504	0.00176	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—LHB—polycystic ovary syndrome	0.000485	0.0017	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000474	0.00166	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SUOX—polycystic ovary syndrome	0.000469	0.00164	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LPCAT2—polycystic ovary syndrome	0.000469	0.00164	CbGpPWpGaD
Zaleplon—AOX1—Disease—GAB1—polycystic ovary syndrome	0.000464	0.00162	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000459	0.00161	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000457	0.0016	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000455	0.00159	CbGpPWpGaD
Zaleplon—AOX1—Disease—NAMPT—polycystic ovary syndrome	0.000452	0.00158	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000449	0.00157	CbGpPWpGaD
Zaleplon—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000449	0.00157	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ISYNA1—polycystic ovary syndrome	0.000436	0.00152	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—POMC—polycystic ovary syndrome	0.000434	0.00152	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000422	0.00148	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKR1C3—polycystic ovary syndrome	0.000422	0.00148	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000421	0.00147	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000421	0.00147	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000418	0.00146	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000417	0.00146	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000415	0.00145	CbGpPWpGaD
Zaleplon—AOX1—Disease—TNRC6B—polycystic ovary syndrome	0.000415	0.00145	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000411	0.00144	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—RRM2—polycystic ovary syndrome	0.000409	0.00143	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000399	0.0014	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—YAP1—polycystic ovary syndrome	0.000394	0.00138	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000391	0.00137	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000389	0.00136	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000382	0.00134	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000382	0.00134	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NAMPT—polycystic ovary syndrome	0.000379	0.00133	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000374	0.00131	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000373	0.0013	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKR1C2—polycystic ovary syndrome	0.00037	0.0013	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TEAD2—polycystic ovary syndrome	0.00037	0.0013	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	0.00037	0.0013	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000368	0.00129	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000367	0.00129	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000359	0.00126	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000358	0.00125	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000356	0.00124	CbGpPWpGaD
Zaleplon—AOX1—Disease—TCF7L2—polycystic ovary syndrome	0.000355	0.00124	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000353	0.00124	CbGpPWpGaD
Zaleplon—AOX1—Disease—SLC2A4—polycystic ovary syndrome	0.000349	0.00122	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000349	0.00122	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000348	0.00122	CbGpPWpGaD
Zaleplon—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000339	0.00119	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	0.000339	0.00119	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	0.000339	0.00119	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000334	0.00117	CbGpPWpGaD
Zaleplon—AOX1—Disease—PRL—polycystic ovary syndrome	0.000333	0.00117	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00033	0.00115	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000326	0.00114	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000321	0.00112	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00032	0.00112	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	0.000315	0.0011	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	0.000314	0.0011	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PNPLA2—polycystic ovary syndrome	0.00031	0.00109	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000307	0.00108	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000307	0.00107	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000305	0.00107	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000303	0.00106	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—TH—polycystic ovary syndrome	0.000301	0.00105	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.0003	0.00105	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000298	0.00104	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SRD5A1—polycystic ovary syndrome	0.000294	0.00103	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000293	0.00103	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000293	0.00102	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—STAR—polycystic ovary syndrome	0.000281	0.000982	CbGpPWpGaD
Zaleplon—AOX1—Disease—NCOR1—polycystic ovary syndrome	0.000279	0.000978	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP19A1—polycystic ovary syndrome	0.000275	0.000963	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000275	0.000961	CbGpPWpGaD
Zaleplon—AOX1—Disease—NRG1—polycystic ovary syndrome	0.000274	0.00096	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000268	0.000937	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000268	0.000937	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000256	0.000896	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HMMR—polycystic ovary syndrome	0.00025	0.000876	CbGpPWpGaD
Zaleplon—AOX1—Disease—MTHFR—polycystic ovary syndrome	0.000247	0.000864	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GNAS—polycystic ovary syndrome	0.000246	0.000859	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000243	0.00085	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000239	0.000838	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HSD3B1—polycystic ovary syndrome	0.000239	0.000835	CbGpPWpGaD
Zaleplon—AOX1—Disease—IRS2—polycystic ovary syndrome	0.000235	0.000822	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NCOR1—polycystic ovary syndrome	0.000234	0.000819	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000224	0.000785	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000222	0.000776	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000222	0.000776	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—LHB—polycystic ovary syndrome	0.000218	0.000762	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	0.000213	0.000744	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	0.000213	0.000744	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—MTHFR—polycystic ovary syndrome	0.000207	0.000724	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	0.000206	0.000721	CbGpPWpGaD
Zaleplon—AOX1—Disease—IRS1—polycystic ovary syndrome	0.000205	0.000718	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	0.000203	0.00071	CbGpPWpGaD
Zaleplon—AOX1—Disease—INS—polycystic ovary syndrome	0.000196	0.000687	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000196	0.000685	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000193	0.000676	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT2—polycystic ovary syndrome	0.00019	0.000664	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	0.00019	0.000664	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	0.000184	0.000643	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	0.000181	0.000633	CbGpPWpGaD
Zaleplon—AOX1—Disease—SERPINE1—polycystic ovary syndrome	0.00018	0.000631	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	0.000177	0.000619	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	0.000173	0.000604	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000172	0.000602	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	0.00017	0.000595	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	0.000168	0.000588	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARG—polycystic ovary syndrome	0.000168	0.000587	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—POMC—polycystic ovary syndrome	0.000165	0.000579	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—INS—polycystic ovary syndrome	0.000164	0.000575	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	0.000159	0.000555	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000157	0.000551	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000157	0.000551	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	0.000157	0.000551	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	0.000156	0.000546	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	0.000154	0.000538	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	0.000149	0.000521	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000146	0.000512	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000146	0.000511	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	0.000137	0.00048	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—TH—polycystic ovary syndrome	0.000135	0.000473	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	0.000133	0.000465	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	0.000131	0.00046	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	0.000128	0.000448	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000124	0.000436	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000124	0.000436	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	0.000124	0.000432	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	0.000123	0.00043	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	0.000121	0.000425	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	0.000115	0.000401	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	0.000113	0.000395	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	0.00011	0.000386	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	0.000105	0.000368	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000104	0.000365	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	9.96e-05	0.000349	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	9.89e-05	0.000346	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—TH—polycystic ovary syndrome	9.77e-05	0.000342	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	9.5e-05	0.000332	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	9.43e-05	0.00033	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	9.29e-05	0.000325	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	8.93e-05	0.000313	CbGpPWpGaD
Zaleplon—AOX1—Disease—IL6—polycystic ovary syndrome	8.58e-05	0.0003	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	8.41e-05	0.000294	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.02e-05	0.000281	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	7.97e-05	0.000279	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	7.59e-05	0.000266	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	7.53e-05	0.000263	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	7.43e-05	0.00026	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—INS—polycystic ovary syndrome	7.38e-05	0.000258	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	7.31e-05	0.000256	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	7.2e-05	0.000252	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.15e-05	0.00025	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.92e-05	0.000242	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	6.71e-05	0.000235	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.37e-05	0.000223	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.17e-05	0.000216	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.95e-05	0.000208	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.72e-05	0.0002	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.64e-05	0.000198	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	5.44e-05	0.00019	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	5.37e-05	0.000188	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—INS—polycystic ovary syndrome	5.34e-05	0.000187	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.33e-05	0.000187	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.25e-05	0.000184	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.54e-05	0.000159	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.42e-05	0.000155	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.15e-05	0.000145	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.71e-05	0.00013	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.53e-05	0.000124	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.35e-05	0.000117	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.12e-05	0.000109	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.53e-05	8.85e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.5e-05	8.73e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.48e-05	8.68e-05	CbGpPWpGaD
